{
  "main_header": {
    "sid": 444125,
    "name": "Ishita Drugs",
    "stock_name": "Ishita Drugs",
    "full_name": "Ishita Drugs & Industries Ltd",
    "name_url": "stocks-analysis/ishita-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "75.00",
    "chg": 1.38,
    "chgp": "1.87%",
    "dir": 1,
    "prev_price": "73.62",
    "mcapval": "22.43 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524400,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE806D01016",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "130 ",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/ishita-drugs-444125-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ishita Drugs & Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ishita-drugs-industries-ltd-is-rated-sell-4002791",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IshitaDrugsIndu_mojoScore_4002791.png",
        "date": "2026-05-21 10:10:22",
        "description": "Ishita Drugs & Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ishita Drugs & Industries Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-industries-ltd-valuation-shifts-signal-renewed-price-attractiveness-3965337",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IshitaDrugsIndu_valuationdot_3965337.png",
        "date": "2026-04-28 08:00:37",
        "description": "Ishita Drugs & Industries Ltd has witnessed a notable improvement in its valuation parameters, shifting from a fair to an attractive rating despite a recent 4.6% decline in its share price. This micro-cap pharmaceutical player’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling entry point relative to its historical averages and peer group, signalling a potential opportunity for discerning investors amid a challenging sector backdrop."
      },
      {
        "title": "Ishita Drugs Gains 6.11%: 2 Key Factors Driving the Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-gains-611-2-key-factors-driving-the-weekly-move-3962798",
        "imagepath": "",
        "date": "2026-04-25 17:08:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Stock opens at Rs.77.00, modest gain despite flat Sensex</p>\n                    <p><strong>21 Apr:</strong> Upgrade to Sell rating announced; stock surges 4.35% to Rs.80.35</p>\n                    <p><strong>22 Apr:</strong> Valuation shift to fair grade; stock dips 3.78% to Rs.77.31</p>\n                    <p><strong>23 Apr:</strong> Recovery rally lifts stock 4.64% to Rs.80.90 despite Sensex decline</p>\n                    <p><strong>24 Apr:</strong> Slight pullback to Rs.80.71; week closes with 6.11% gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cl..."
      },
      {
        "title": "Ishita Drugs & Industries Ltd Downgraded to Strong Sell Amid Technical Weakness and Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ishita-drugs-industries-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-flat-financials-3945189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IshitaDrugsIndu_mojoScore_3945189.png",
        "date": "2026-04-14 08:17:57",
        "description": "Ishita Drugs & Industries Ltd has been downgraded from a Sell to a Strong Sell rating as of 13 Apr 2026, reflecting deteriorating technical indicators and persistently weak financial fundamentals. Despite some long-term outperformance relative to the Sensex, the company’s micro-cap status, flat recent financial results, and bearish technical signals have prompted a reassessment of its investment appeal."
      },
      {
        "title": "Ishita Drugs & Industries Ltd: Valuation Shifts Signal Price Attractiveness Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-industries-ltd-valuation-shifts-signal-price-attractiveness-amid-market-volatility-3923273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IshitaDrugsIndu_valuationdot_3923273.png",
        "date": "2026-03-30 08:00:53",
        "description": "Ishita Drugs & Industries Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade. Despite a recent sharp decline in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 10,
    "sid": "444125",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/ishita-drugs-industries-444125"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May 2026",
      "datetime": "30-May-2026",
      "details": "Outcome of Board Meeting held on 30th May 2026",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting Held On 30Th May 2026",
      "datetime": "30-May-2026",
      "details": "Audited Financial Results for the quarter and year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 For The Quarter And Year Ended 31St March 2026",
      "datetime": "23-May-2026",
      "details": "Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To consider approve and take on records the Audited Financial Results of the Company for the quarter and year ended 31st March 2026 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 2. To consider and approve the Directors Report with the Annexure Corporate Governance Report Management Discussion and Analysis Report and Notice for convening the 33rd Annual General Meeting of the Company. 3. To consider the re-appointment of Internal Auditors of the Company for the year 2026-27. 4. To take on record Disclosure of Interest of Directors. 5. Any other matter with permission of the Chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ishita Drugs & Industries Ltd is Rated Sell

2026-05-21 10:10:22

Ishita Drugs & Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read More

Ishita Drugs & Industries Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-04-28 08:00:37

Ishita Drugs & Industries Ltd has witnessed a notable improvement in its valuation parameters, shifting from a fair to an attractive rating despite a recent 4.6% decline in its share price. This micro-cap pharmaceutical player’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling entry point relative to its historical averages and peer group, signalling a potential opportunity for discerning investors amid a challenging sector backdrop.

Read More

Ishita Drugs Gains 6.11%: 2 Key Factors Driving the Weekly Move

2026-04-25 17:08:19

Key Events This Week 20 Apr: Stock opens at Rs.77.00, modest gain despite flat Sensex 21 Apr: Upgrade to Sell rating announced; stock surges 4.35% to Rs.80.35 22 Apr: Valuation shift to fair grade; stock dips 3.78% to Rs.77.31 23 Apr: Recovery rally lifts stock 4.64% to Rs.80.90 despite Sensex decline 24 Apr: Slight pullback to Rs.80.71; week closes with 6.11% gain Week Open<div cl...

Read More

Ishita Drugs & Industries Ltd Downgraded to Strong Sell Amid Technical Weakness and Flat Financials

2026-04-14 08:17:57

Ishita Drugs & Industries Ltd has been downgraded from a Sell to a Strong Sell rating as of 13 Apr 2026, reflecting deteriorating technical indicators and persistently weak financial fundamentals. Despite some long-term outperformance relative to the Sensex, the company’s micro-cap status, flat recent financial results, and bearish technical signals have prompted a reassessment of its investment appeal.

Read More

Ishita Drugs & Industries Ltd: Valuation Shifts Signal Price Attractiveness Amid Market Volatility

2026-03-30 08:00:53

Ishita Drugs & Industries Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade. Despite a recent sharp decline in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value in the Pharmaceuticals & Biotechnology sector.

Read More

View All News